Cytokine Release Assays as Tests for Exposure to Leishmania, and for Confirming Cure from Leishmaniasis, in Solid Organ Transplant Recipients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytokine Release Assays as Tests for Exposure to Leishmania, and for Confirming Cure from Leishmaniasis, in Solid Organ Transplant Recipients
Authors
Keywords
Leishmaniasis, Blood, Cytokines, Leishmania, Blood plasma, Immune response, Enzyme-linked immunoassays, Solid organ transplantation
Journal
PLoS Neglected Tropical Diseases
Volume 9, Issue 10, Pages e0004179
Publisher
Public Library of Science (PLoS)
Online
2015-10-24
DOI
10.1371/journal.pntd.0004179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: a retrospective multicenter case–control study
- (2015) W. Clemente et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk Assessment of Tuberculosis in Immunocompromised Patients. A TBNET Study
- (2014) Martina Sester et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Asymptomatic Leishmania Infection: A New Challenge for Leishmania Control
- (2014) O. P. Singh et al. CLINICAL INFECTIOUS DISEASES
- Leishmaniasis in immunosuppressed individuals
- (2014) J. van Griensven et al. CLINICAL MICROBIOLOGY AND INFECTION
- In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis
- (2014) Rym Chamakh-Ayari et al. PLoS One
- High Prevalence of AsymptomaticLeishmaniaspp. Infection Among Liver Transplant Recipients and Donors From an Endemic Area of Brazil
- (2013) W. T. Clemente et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis
- (2013) Augusto M Carvalho et al. BMC INFECTIOUS DISEASES
- Comparison of Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV Quantiferon Gamma Interferon-Releasing Assays in Assessing Risk of CMV Infection in Kidney Transplant Recipients
- (2013) D. Abate et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Interferon-γ release assays versus tuberculin skin test for targeting people for tuberculosis preventive treatment: An evidence-based review
- (2013) Laura Muñoz et al. JOURNAL OF INFECTION
- Characterization of the biology and infectivity of Leishmania infantum viscerotropic and dermotropic strains isolated from HIV+ and HIV- patients in the murine model of visceral leishmaniasis
- (2013) Joana Cunha et al. Parasites & Vectors
- What is responsible for a large and unusual outbreak of leishmaniasis in Madrid?
- (2013) Eugenia Carrillo et al. TRENDS IN PARASITOLOGY
- Reassessment of Immune Correlates in Human Visceral Leishmaniasis as Defined by Cytokine Release in Whole Blood
- (2012) Om Prakash Singh et al. Clinical and Vaccine Immunology
- Visceral leishmaniasis reactivation in transplant patients: a minireview with report of a new case
- (2011) Maria Concetta Postorino et al. JOURNAL OF NEPHROLOGY
- Quantiferon-Leishmania as an Epidemiological Tool for Evaluating the Exposure to Leishmania Infection
- (2010) Nevin Turgay et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis
- (2009) Guadalupe Miró et al. VETERINARY DERMATOLOGY
- Leishmaniasis among organ transplant recipients
- (2008) Spinello Antinori et al. LANCET INFECTIOUS DISEASES
- Combined diagnostic methods identify a remarkable proportion of asymptomatic Leishmania (Leishmania) chagasi carriers who present modulated cytokine profiles
- (2008) Luciana de Gouvêa Viana et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started